Cargando…
Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose
With the challenge of optimizing iron delivery, new intravenous (iv) iron–carbohydrate complexes have been developed in the last few years. A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266270/ https://www.ncbi.nlm.nih.gov/pubmed/25525337 http://dx.doi.org/10.2147/DDDT.S55499 |